Evaluation of Four Qualitative Third-Generation HIV Antibody Assays and the Fourth-Generation Abbott HIV Ag/Ab Combo Test.

Objective: Compare the agreement between four third-generation rapid or automated human immunodeficiency virus (HIV) tests vs the fourth-generation Abbott ARCHITECT HIV Ag/Ab Combo assay (Combo Test) (Abbott Laboratories, Abbott Park, IL) in 7 clinical laboratories located throughout the Dallas-Fort...

Descripción completa

Detalles Bibliográficos
Publicado en:Laboratory Medicine Vol. 42; no. 9; pp. 523 - 536
Autores principales: Wians Jr, Frank H., Moore, Holly A., Briscoe, Donna, Anderson, Kathy M., Hicks, Pamela S., Smith, Debbie L., Clark, Tammy A., Preston, Maggie M., Gammons, Beckie, Ray, Cynthia S., Bond, Christine, West, Joshua T.
Formato: algorithm pictorial research tables/charts Journal Article
Publicado: Oxford University Press / USA Sep2011
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104626561&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104626561
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00075027
        4CY
      jtl: Laboratory Medicine
      issn: 00075027
      maglogo: N
    pubinfo:
      dt: Sep2011
      vid: 42
      iid: 9
      pid: 10398
      pub: Oxford University Press / USA
    artinfo:
      ui:
        104626561
        70268071
        10.1309/LM38NCGQ0GWJIMZV
        104626561
      ppf: 523
      ppct: 13
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Evaluation of Four Qualitative Third-Generation HIV Antibody Assays and the Fourth-Generation Abbott HIV Ag/Ab Combo Test.
      aug:
        au:
          Wians Jr, Frank H.
          Moore, Holly A.
          Briscoe, Donna
          Anderson, Kathy M.
          Hicks, Pamela S.
          Smith, Debbie L.
          Clark, Tammy A.
          Preston, Maggie M.
          Gammons, Beckie
          Ray, Cynthia S.
          Bond, Christine
          West, Joshua T.
        affil: Department of Pathology, Baylor University Medical Center, Dallas
      sug:
        subj:
          AIDS Serodiagnosis Methods
          Chemistry, Clinical Methods
          Human Immunodeficiency Virus Analysis
          Antigens, Viral Blood
          Antibodies, Viral Blood
          Human
          Comparative Studies
          Geographic Factors
          McNemar's Test
          Nucleic Acid Amplification Techniques
          Blotting, Western
          Time Factors
          Early Diagnosis
          Immunoenzyme Techniques
          Sensitivity and Specificity
          Predictive Value of Tests
          Confidence Intervals
          Reagent Kits, Diagnostic Evaluation
          False Negative Results
          False Positive Results
          Funding Source
          Seroconversion
      ab: Objective: Compare the agreement between four third-generation rapid or automated human immunodeficiency virus (HIV) tests vs the fourth-generation Abbott ARCHITECT HIV Ag/Ab Combo assay (Combo Test) (Abbott Laboratories, Abbott Park, IL) in 7 clinical laboratories located throughout the Dallas-Fort Worth, TX, metroplex area. Methods: We tested a total of 220 specimens from the general population of patients being screened for HIV antibody status, including Western blot (WB) and HIV-1 RNA viral load by NAAT in patients with initially positive HIV screening tests. We performed a method precision study of the Combo Test and evaluated the agreement between the 4 comparative methods (CMs) against the Combo Test method (TM) using a 2 × 2 contingency table to determine values for positive percent agreement (PPA), negative percent agreement (NPA), and overall percent agreement (OPA) according to the guideline (EP12-A2) for the evaluation of qualitative assays published by the Clinical Laboratory Standards Institute (CLSI). Results: The Combo Test yielded consistent (reproducible) results when the HIV antibody (or p24 antigen) concentration was 20% away or more from C50. In addition, values for PPA, NPA, and OPA for CM vs TM results were all 100%, or not significantly different from 100%. Conclusion: The high detection rate of the Combo Test, when coupled with its high diagnostic sensitivity and specificity, rapid TAT (<30 minutes) of test results using a fully automated instrument (ARCHITECT), and excellent agreement with HIV-1/2 antibody results by several commercially available HIV-1/2 screening tests and with WB and NAAT results, indicate that the Abbott HIV-1/2 Ab/Ag Test is a useful screening test in the identification of HIV-infected individuals.
      pubtype: Academic Journal
      doctype:
        algorithm
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N